Tech Company Financing Transactions
Multiply Labs Funding Round
NantWorks, AstraZeneca and Casdin Capital participated in a $75 million Series B venture round for Multiply Labs. The round was announced on 10/6/2026.
Transaction Overview
Company Name
Announced On
10/6/2026
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series B
Investors
Proceeds Purpose
The company will use the capital to expand its core robotics and hardware engineering teams, accelerate the industrial manufacturing of its automated cell and gene therapy production lines, and fund commercial deployment operations across North America and Europe.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
San Francisco, CA 94124
USA
San Francisco, CA 94124
USA
Phone
Undisclosed
Website
Email Address
Overview
We observed that our families, friends and coworkers would continuously construct their days around taking pills as opposed to constructing pills around their days. We see a future where people no longer have to take more than one pill a day.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fred Parietti
Chief Scientific Officer
Alice Melocchi
VP - Manufacturing
Jeffrey Curhan
Browse more venture capital transactions:
Prev: 10/6/2026: Finches venture capital transaction
Next: 10/6/2026: Edonia venture capital transaction
Share this article
Where The Data Comes From
We record tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs